Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by the presence of the BCR-ABL fusion gene, resulting from a translocation between chromosomes 9 and 22 (Philadelphia chromosome) [1]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.